Loading
No insider purchase over the last 90 days. The latest, by 양현구, was filed 10 Jun 2026.
NH Nongwoobio Co., Ltd.: what insiders have been doing
Every trade that managers of NH Nongwoobio Co., Ltd. disclose to DART (FSS) is tracked on this page. The company sits in the Chemicals sector. From 24 October 2025 to 24 October 2026, the disclosure feed for NH Nongwoobio Co., Ltd. logged 2 filings by 2 insiders.
Only purchases show up on the open market, 1 purchase in all, filed by 1 insider. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 1 chief executive.
For context, the typical company on the same exchange (median of 2,650 companies) published 7 filings over the same period, against 2 filings here. Over the whole record (from 2021), the tally stands at 6 purchases and no sales.
The most recent open-market purchase was published on 10 June 2026, 138 days ago.
In the same sector, recent insider purchases at Titan and Norske Skog ASA also feature in our signals. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Insider Decl.
10
Thresholds
n/a
Buy Volume
€36,825
6 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySale양현구1 buy
Since the insiders bought
- -6.0%Entry ₩7,800 · Close at T+365 ₩7,330
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 3,464 of 26,320 companies
71.5
score / 100
Value83
Quality60
FCF yld8.7%
Earn yld11%
EV/EBITDA6.1x
ROE4.6%
Gross mgn49%
Net mgn7.7%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
₩6,950
Analyst consensus
Income statement
Revenue₩158.8B
Gross profit₩77.8B49% margin
EBITDA₩22.6B14% margin
Net income₩12.3B8.1% margin
Valuation
Beta0.50
Balance sheet & cash
Market cap₩111.4B
Total debt₩26B
Free Cash Flow₩9.7B
Debt / Equity9%
Profitability & ownership
ROE4.6%
ROA1.9%
% insiders58.0%
% institutions0.2%
Last declaration on 10 June 2026
Declarations10 total
4,000 sharesShareKRXDART:20260610000459
Canonical exit: 8 Sept 2026 (T+90)
●
Executives
0DART
●
Executives
0DART
2,000 sharesShareKRXDART:20241018000160
Canonical exit: 16 Jan 2025 (T+90)
1,000 shares@ ₩8,050.0050.1% of flowShareKRXDART:20240415000977
Canonical exit: 10 Jul 2024 (T+90)
1,000 shares@ ₩8,020.0549.9% of flowShareKRXDART:20240409002886
Canonical exit: 8 Jul 2024 (T+90)
●
Executives
0DART
●
Executives
0DART
ShareKRXDART:20210330001482
Canonical exit: 28 Jun 2021 (T+90)
ShareKRXDART:20210222001972
Canonical exit: 23 May 2021 (T+90)
10 of 10 declarations
About NH Nongwoobio Co., Ltd.
NH농우바이오 is a company in the chemical and materials sector, listed on the XKRX. It focuses on the development and production of biological and chemical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
